Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases | Zendy

Oğuz Reşat Sıpahı | Zendy; Hasip Kahraman | Zendy; Sinan Mermer | Zendy; Hüsnü Pullukçu | Zendy; Meltem Taşbakan | Zendy; Bilgin Arda | Zendy; Tansu Yamazhan | Zendy; Taşkın Yurtseven | Zendy; Şöhret Aydemir | Zendy; Sercan Ulusoy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases

Author(s) -

Oğuz Reşat Sıpahı,

Hasip Kahraman,

Sinan Mermer,

Hüsnü Pullukçu,

Meltem Taşbakan,

Bilgin Arda,

Tansu Yamazhan,

Taşkın Yurtseven,

Şöhret Aydemir,

Sercan Ulusoy

Publication year - 2014

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2014.01.027

Subject(s) - spondylodiscitis , tigecycline , medicine , surgery , general surgery , antibiotics , microbiology and biotechnology , biology

Tigecycline is a relatively new glycylcycline antimicrobial, active in vitro against a variety of Gram-positive and Gram-negative organisms. In this study we evaluated the outcomes of spondylodiscitis cases treated with tigecycline-including therapies retrospectively.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research